Views & Analysis A new fast track for NHS access - good news for niche innova... The UK is about to launch The Accelerated Access Collaborative: a new initiative aimed at speeding potential breakthroughs to market.
News NICE to play key role in UK drug fast-track scheme Former GSK CEO Sir Andrew Witty will oversee proceedings.
News Analysis: UK’s new ‘breakthrough’ status welcome, but drug c... A new ‘breakthrough’ status for innovative new medicines and technologies has been
Oncology On the forefront of healthcare change, turning innovative sc... Claus Zieler, chief commercial and medical affairs officer & member of the Executive Committee at Astellas Pharma, spoke with pharmaphorum at ASCO25.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face